Are you ready to talk to one of our fertility experts about individualized care?
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among females, producing symptoms in approximately 5% to 10% of women of reproductive age. Such symptoms should include at least two of three of the following: (1) irregular menstrual cycles, (2) clinical and or biochemical (through laboratory assessment) hyperandrogenism, and (3) polycystic appearing ovaries on ultrasound. Notably, PCOS is generally a diagnosis of exclusion, which means that all other causes for the presenting symptoms should be excluded. Additionally, up to 20% of women without PCOS will have polycystic appearing ovaries on ultrasound.
PCOS has both reproductive and medical consequences to the affected woman. From a reproductive standpoint, the woman may suffer from anovulatory infertility. From a medical standpoint, affected women are at an increased risk for obstructive sleep apnea, depression, insulin resistance, type 2 diabetes, and metabolic syndrome. As such, women with polycystic ovary syndrome should be screened for these outcomes on a regular basis, and treated appropriately.
If identified, your Team RMI physician will treat both the reproductive and metabolic consequences of this disease.